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Abstract New paramagnetic retinal analogues have been synthesized by 
Horner-Wadsworth-Emmons and Wittig reactions. In these new analogues 
the pyrroline nitroxide moiety is situated in the place of -ionone ring or at 
the end of the polyene chain.
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Introduction
The use of retinal and its synthetic analogues to probe the binding site and 
the  photochemistry  of  both  the  visual  pigment  rhodopsin  and 
bacteriorhodopsin have been well established. Paramagnetic modifications 
of retinal have also been published earlier [1, 2]. These efforts are  part of a 
tendency to determine the accessibility and penetration of small molecules 
to  specific  sites  of  proteins.  The mechanism by which small  molecules 
reach various domains in proteins is of fundamental interest in the study of 
protein dynamics and enzyme mechanisms [3]. Retinal and its metabolites 
(retinoids) are essential to the proper function of a number of biological 
processes.  Visual cycle is perhaps the most thoroughly described field, but 
reproduction,  cell  growth  and  differentiation,  embryonic  development, 
immune response and intermediacy metabolism are also regulated by all-E 
retinoic acid and 9-Z-retinoic acid [4]. The role of retinal and retinoids in 
antioxidant  defense  is  still  controversial:  they  are  used  in  treatment  of 
diseases associated with oxidative stress, but several studies report that they 
may increase oxidative stress by impairing mitochondrial function [5].  
In  our  laboratory  we  have  a  long-standing  interest  to  synthesize 
paramagnetic analogues of amino acids [6], carbohydrates [7], drugs [8, 9] 
and antioxidants [10] to study the receptor binding by EPR spectroscopy 
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[7-9]  and  to  study  their  antioxidant  properties.  Most  of  these 
paramagnetically modified molecules exhibited better antioxidant activity 
than the original biomolecules did [9, 10].   As art of our ongoing interest, 
in the synthesis of spin labeled biomolecules we have lately focused on the 
synthesis  of  paramagnetic  analogues  of  diterpenes  such  as  retinal  and 
paramagnetic  retinoic  acid.  Although  paramagnetic  analogues  2,  3  of 
retinal 1 has been synthesized earlier [1, 2] (Figure 1), we envisioned that 
18  methyl  group  insertion  for  compound  4 as  well  as  incorporating 
pyrroline ring into aldehyde end of retinal molecule 5 may open up further 
perspectives and challenges in the study of retinal function and biological 
activity. To the best of our knowledge, paramagnetic retinal analogues with 
bulky substituents on the retinal polyene chains have not been synthesized 
so far, although several diamagnetic analogue syntheses and studies have 
been published concluding that these modifications block  the chromophore 
binding  or  slow  down  the  13-Z  all-E isomerization  [11-13].     The 
challenge of synthesizing carotenoids and retinal derivatives inspired many 
distinguished organic chemists both in laboratories and in the industry [14], 
however reports on spin labeled retinal derivatives are still limited [1, 2], 
probably because of the difficulty of utilization of organometallic reagents 
in the presence of nitroxides and the difficulties of NMR investigation of 
paramagnetic species formed. In this paper we report the extension of the 
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Horner-Wadsworth–Emmons  olefination  and  Wittig  reaction-based 
approach for paramagnetic retinal  and retinoic acid synthesis  for  further 
biological  studies  including  antioxidant  and  receptor-binding 
investigations.
< Fig. 1 >
Results and Discussion
We  began  our  synthesis  with  1-oxyl-2,2,4,5,5-pentamethyl-2,5-dihydro-
1H-pyrrol-3-carbaldehyde  6 available by Suzuki reaction [15]. For chain 
elongation  compound  6 was  treated  with  the  anion  of  ethyl  4-
diethoxyphosphinyl-3-methyl-2-butenoate  [16]  in  THF at  -78  °C  giving 
compound  7.  Transformation  of  the  ester  group  into   aldehyde  by  the 
previously reported protocols [1, 2] did not give satisfactory results in our 
hands.  Therefore the resulting ester 7 was hydrolyzed to carboxylic acid 8 
cautiously in aqueous sodium hydroxide-methanol solution. Compound  8 
was converted to mixed anhydride ester  with ethyl chloroformate in the 
presence  of  Et3N  and  this  was  reduced  with  1.1  equivalent  sodium 
borohydride in ethanol to an alcohol [17]. Oxidation of this alcohol with 
activated MnO2 provided  aldehyde 9. 
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The configuration of two double bonds in the chain of  9  was  proven by 
HMQC, HMBC COSY and NOESY measurements and were found to be 
E,E-isomers. Further elongation of the chain from aldehyde 9 with lithium 
salt of ethyl 4-diethoxyphosphinyl-3-methyl-2-butenoate in THF at -78 °C 
gave  ester 10. The 2D measurements,  1H NMR and 13C NMR  studies of 
compound 10  suggested the presence of both Z and E isomers. This was 
also confirmed by HPLC studies [18] revealing that the product contains 
33% 11-Z-isomer and 64% all  E-isomer and further 2 minor isomers in 1 
and 2 %. Compound 10 was hydrolyzed with aqueous sodium hydroxide in 
methanol to the paramagnetic analogue of retinoic acid 11. This acid was 
converted to mixed anhydride ester, which was reduced with 1.1 equivalent 
NaBH4 in ethanol at 0 °C and the alcohol achieved was not isolated, but 
oxidized immediately to   paramagnetic retinal  4  with activated MnO2 in 
CH2Cl2  at room temperature (Figure 2).  The 2D measurements,  1H NMR 
and 13C NMR  studies of compound 4  suggested the presence of both Z and 
E isomers also. This was confirmed by HPLC studies as well, confirming 
that paramagnetic retinal analogue contains of 24% 11-Z-isomer and 73% 
of all E-isomer and 0.5% and 2 % of another two minor isomers.  
< Figure 2 >
To study further the steric constrainsts in the retinal binding pocket by EPR 
spectroscopy  we  envisioned  that  the  paramagnetic  13-Z-locked  retinal 
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analogue might be a useful substrate. To incorporate the pyrroline ring into 
C(13)-C(14)  positions   of  the  retinal  molecule  we  used  1-oxyl-4-
(hydroxymethyl)-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-
carbaldehyde  12 [19]   as  a  starting  material.  It  was  silylated  on  the 
hydroxyl group [20] and treatment of   aldehyde  13  with ylide, generated 
from -ionylidenethyltriphenylphosphonium bromide [21] with LDA at -78 
°C in THF, gave the mixture of silylated and desilylated products.  After 
removing the silyl group from the crude product with Bu4NF in THF during 
the work-up, we got alcohol 14. Oxidation of compound 14 with activated 
MnO2 in CH2Cl2 at room temperature provided aldehyde 5, a paramagnetic 
retinal derivative with C(13)-C(14) Z double bond. Otherwise structure of 
compound  5 was confirmed using HMQC, HMBC, COSY, NOESY and 
revealed the E configuration for all three double bond in question.
< Figure 3 > 
Conclusion
In this study, some new paramagnetic retinal  4, 5 and retinoic acid 
11 analogues  have been synthesized by Horner-Wadsworth-Emmons and 
Wittig reactions incorporating the nitroxide moiety into the two ends of 
retinal structure, respectively. We are confident that the new paramagnetic 
retinal and retinoic acid analogues reported herein will find utilization in 
both antioxidant and receptor binding studies, and hopefully methodologies 
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described will be applicable in accessing other biomolecules modified by a 
nitroxide moiety.
Experimental
Melting  points  were  determined  with  a  Boetius  micro  melting  point 
apparatus. Elemental analyses were performed on Fisons EA 1110 CHNS 
elemental analyzer. Results were found to be in good agreement (±0.3%) 
with the calculated values. Mass spectra were recorded on a Thermoquest 
Automass Multi.  1H NMR spectra were recorded with Bruker Avance 3 
Ascend 500. Chemical shifts are referenced to Me4Si. The paramagnetic 
compounds were reduced with hydrazobenzene. Measurements were run at 
298K probe temperature in CDCl3 solution.  ESR spectra  were taken on 
Miniscope MS 200 in 10-4 M CHCl3 solution and all monoradicals
gave triplet line aN = 14.4 G. The IR spectra were taken with Bruker Alpha 
FT-IR  instrument with ATR support on diamond plate. UV spectra were 
taken with Specord 40 instrument (Analytic Jena). The HPLC system was 
interfaced to a gradient pump Dionex P680 and  Dionex PDA-100 detector; 
the  acquisitions  was  performed  =  450  nm  detection  at  22oC.   Data 
acquisitions  were  performed  by  Chromeleon  6.70  software.  The  HPLC 
separations were carried out on an end-capped column (250 x 4.6 mm i.d.; 
YMC C30, 3µm). The eluents consisted of: A: 81% MeOH, 15% TBME, 
4% H2O and  B: 6% MeOH, 90% TBME, 4% H2O.  Linear gradient was 
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used: 0’ 100% A – 15’ 85% A, 15% B eluent and  flow rate was 1.00 
cm3/min.    Flash  column  chromatography  was  performed  on  Merck 
Kieselgel  60  (0.040-0.063  mm).  Qualitative  TLC  was  carried  out  on 
commercially  available  plates  (20  x  20  x  0.02  cm)  coated  with  Merck 
Kieselgel GF254. Compounds 6 [15], 12 [19], ethyl 4-diethoxyphosphinyl-
3-methyl-2-butenoate  [16],  -ionylidenethyltriphenyl-phosphonium 
bromide [21] were prepared according to published procedures and other 
reagents were purchased from Aldrich. 
General procedure for Horne –Wadsworth –Emmons reaction
A solution of BuLi (2.4 mL, 6.0 mmol, 2.5M in hexanes) was added 
dropwise at -78 °C to a stirred solution of 4-diethoxyphosphinyl-3-methyl-
2-butenoate (1.98 g, 7.5 mmol) in anhydr. THF (20 mL). The mixture was 
stirred under N2 at this temperature for 30 min, then aldehyde 6 (910 mg, 
5.0 mmol) or aldehyde 9 (1.24 g, 5.0 mmol) was added dropwise in THF 
(10 mL) at -78 °C. The mixture was stirred at this temperature for 30 min., 
and then it  was allowed to warm to room temperature and was  stirred 
overnight.  Following  the  addition  of  sat.  aq.  NH4Cl  solution  (10  mL), 
EtOAc  (20  mL)  was  added  and  the  organic  phase  was  separated.  The 
aqueous phase was extracted with EtOAc (10 mL), the combined organic 
phase  was  dried  (MgSO4),  filtered  and  evaporated.  The  residue  was 
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purified  by  flash  column  chromatography  with  gradient  elution 
(hexane/ether: 90%/10% to 60%/40%) to furnish compounds 7 as a yellow 
and 10 as  deep yellow solids.
(2E,4E)-Ethyl  5-(1-oxyl-2,2,4,5,5-pentamethyl-2,5-dihydro-1H-pyrrol-3-
yl)-3-methylpenta-2,4-dienoate  Radical  C17H26NO3 (7):   605  mg  (48%), 
Mp.: 53° C, Rf: 0.40 (hexane/Et2O 2:1). IR (neat):   = 1701, 1645, 1606 
cm-1; UV-Vis (ethanol, c = 2.36 .10-5 mol dm-3): max () = 303 (26400) nm 
(mol-1 dm3 cm-1); MS (70 eV): m/z = 292 (M+, 100), 277 (32), 262 (23), 91 
(83).
Ethyl  9-(1-oxyl-2,2,4,5,5-pentamethyl-2,5-dihydro-1H-pyrrol-3-yl)-3,7-
dimethylnona-2,4,6,8-tetraenoate Radical C22H32NO3 (10) : 698 mg (39%). 
Mp.: 98 °C, Rf: 0.35 (hexane/Et2O 2:1).  1H NMR (500 MHz, CDCl3) δ = 
1.30 (s, 6H, CH3), 1.28 (t, 3H, CH3), 1.45 (, 6H, CH3), 1.86 (s, 3H, CH3), 
2.09 (s, 3H, CH3), 2.45 (s, 3H, CH3), 4.27 (m, 2H, CH2), 6.22 (d, 1H, CH), 
6.31 (d, 1H, CH), 6.40 (dd, 1H, CH), 6.57 (d, 1H, CH), 6.67 (d, 1H, CH), 
7.06 (m, 1H, CH);  13C NMR (125 MHz, CDCl3) δ = 10.80 (CH3), 13.72 
(CH3), 14.25 (CH3), 23.87 (CH3), 24.99 (CH3), 25.60 (CH3), 59.56 (CH2), 
68.76  (C),  69.50  (C),  121.67  (CH),  130.44  (CH),  130.57  (CH),  131.99 
(CH),  133.70  (CH),  135.46  (C),  135.68  (CH),  138.68  (C),  139.26  (C), 
142.66 (C), 167.02 (C). IR (neat):   = 1694, 1601, 1569 cm-1; UV-Vis 
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(ethanol,  c = 2.24 .10-5 mol dm-3):  max () = 361 (52100), 262 (4500) nm 
(mol-1 dm3 cm-1); MS (70 eV): m/z = 358 (M+, 2), 344 (28), 328 (11), 192 
(79).
General procedure for ester hydrolysis:
10% aq. NaOH (10 mL) was added  to a solution of ester 7 (1.17g, 
4.0 mmol) or  10 (1.43 g, 4.0 mmol) in MeOH (20 mL). The mixture was 
allowed to stand overnight at ambient temperature in the dark. The MeOH 
was  evaporated  in  vacuo (<  40 °C),  and the  pH was  adjusted  to  4  by 
cautious  addition  of  5%  H2SO4  at  0  °C.  Then  the  aqueous  phase  was 
immediately extracted with CHCl3 (2 x 15 mL). The organic phase was 
dried (MgSO4), filtered and evaporated. The carboxylic acids 8 and 11 were 
isolated as yellow solids after flash column chromatography by gradient 
elution  (hexane/EtOAc  66%/33%  for  5  x  30  mL  fraction  and  then 
CHCl3/Et2O from 10%/90% to 50%/50% ).
(2E,4E)-5-(1-Oxyl-2,2,4,5,5-pentamethyl-2,5-dihydro-1H-pyrrol-3-yl)-3-
methylpenta-2,4-dienoic acid Radical C15H22NO3 (8):  443 mg (42%), Mp.: 
152 °C, Rf : 0.33 (CHCl3/Et2O 2:1). IR (neat):  = 3034, 1674, 1602, 1584 
cm-1; UV-Vis (ethanol, c = 2.74 .10-5 mol dm-3): max () = 299 (25300) nm 
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(mol-1 dm3 cm-1); MS (70 eV):  m/z = 264 (M+, 13), 249 (14), 234 (8), 43 
(100).
9-(1-Oxyl-2,2,4,5,5-pentamethyl-2,5-dihydro-1H-pyrrol-3-yl)-3,7-
dimethylnona-2,4,6,8-tetraenoic  acid  Radical  C20H28NO3  (11):  462  mg 
(35%). Mp.: 208 °C, Rf 0.27 (CHCl3/Et2O 2:1). IR (neat):  = 3046, 1672, 
1596, 1564 cm-1; UV-Vis (ethanol, c = 1.68 .10-5 mol dm-3): max () = 257 
(4000), 357 (51700) nm (mol-1 dm3 cm-1); MS (70 eV): m/z = 330 (M+, 9), 
316 (8), 300 (5), 282 (15), 91 (68) 44 (100).
General procedure for conversion of acids to aldehydes
To a stirred solution of  carboxylic acids  8  (2.0 mmol) or  11 (2.0 
mmol)  and  Et3N (404  mg,  4.0  mmol)  in  anhydr.  Et2O (20  mL)  ethyl-
chloroformate (217 mg, 2.0 mmol) in Et2O (5 mL) was added dropwise at 0 
°C.  The  mixture  was  stirred  at  this  temperature  for  3h,  then  the 
trierthylamine  hydrochloride  was  filtered  off  on  glass  sintered  funnel, 
washed with Et2O (10 mL) and the ether was evaporated off in vacuo (< 40 
°C).  The residue was immediately dissolved  in  dry EtOH (15 mL) and 
NaBH4 (84 mg, 2.2 mmol) was added in 3 portions during 30 min. at 0 °C. 
After the consumption of the starting mixed anhydride ester, monitored by 
TLC (~ 90 min.), the EtOH was evaporated off (< 40 °C), the residue was 
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dissolved in CHCl3 (20 mL), washed with brine (10 mL) and the organic 
phase  was  dried  (MgSO4),  filtered  and  evaporated.  The  residue  was 
immediately dissolved in dry CH2Cl2 (20 mL),  activated MnO2 (1.72 g, 
20.0  mmol)  was  added  in  one  portion  and  stirred  overnight  at  room 
temperature in the dark.  Then the reaction mixture was filtered through 
Celite, washed with CH2Cl2 (10 mL), the solvent was evaporated and the 
residue  was  purified  by  flash  column  chromatography  (gradient: 
hexane/Et2O 90%/10% to  75%/25% 10 x  30 mL  then   hexane/EtOAc 
60%/40%) to give aldehydes 9 and 4 as yellow solids.
(2E,4E)-5-(1-Oxyl-2,2,4,5,5-pentamethyl-2,5-dihydro-1H-pyrrol-3-yl)-3-
methylpenta-2,4-dienal Radical  C15H22NO2  (9):  153 mg (35%). Mp.:  104 
°C, Rf 0.17 (hexane/Et2O 2:1). 1H NMR (500 MHz, CDCl3) δ = 1.31 (s, 6H, 
CH3), 1.44 (s, 6H, CH3), 1.87 (s, 3H, CH3), 2.37 (s, 3H, CH3), 6.09 (d, 1H, 
CH), 6.55 (d, 1H, CH), 6.82 (d, 1H, CH), 10.20 (s, 1H, CHO);  13C NMR 
(125  MHz,  CDCl3)  δ  =  11.14  (CH3),  12.79  (CH3),  23.97  (CH3),  25.11 
(CH3),  68.70  (C),  69.78  (C),  128.12  (CH),  129.38  (CH),  131.83  (CH), 
135.32 (C), 144.84 (C), 154.82 (C), 191.09 (CHO). IR (neat):   = 1649, 
1616, 1600 cm-1; UV-Vis (ethanol, c = 2.71 .10-5 mol dm-3): max () = 323 
(32600) nm (mol-1 dm3 cm-1); MS (70 eV): m/z = 248 (M+, 78), 218 (11), 91 
(82), 42 (100).
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9-(1-Oxyl-2,2,4,5,5-pentamethyl-2,5-dihydro-1H-pyrrol-3-yl)-3,7-
dimethylnona-2,4,6,8-tetraenal Radical C20H28NO2 (4): 157 mg (25%), Mp.: 
140 °C, Rf 0.47 (hexane/EtOAc 2:1). 1H NMR (500 MHz, CDCl3) δ = 1.30 
(s, 6H, CH3), 1.44 (s, 6H, CH3), 1.86 (s, 3H, CH3), 2.10 (s, 3H, CH3), 2.38 
(s, 3H, CH3), 6.24 (d, 1H, CH), 6.33 (d, 1H, CH), 6.46 (d, 1H, CH), 6.56 (d, 
1H, CH), 6.66 (d, 1H, CH), 7.20 (m, 1H, CH), 10.17 (s, 1H, CH); 13C NMR 
(125  MHz,  CDCl3)  δ  =  10.87  (CH3),  13.01  (CH3),  23.80  (CH3),  24.94 
(CH3),  25.54  (CH3),  68.88  (C),  69.67  (C),  122.56  (CH),  129.16  (CH), 
130.73 (CH), 131.97 (CH), 133.53 (CH), 135.06 (CH), 135.46 (C), 140.59 
(C), 140.93 (C), 142.62 (C), 190.97 (CH).
IR (neat):  = 1652, 1597, 1567 cm-1; UV-Vis (ethanol, c = 1.98.10-5 mol 
dm-3):  max () = 377 (33600), 270 (10800) nm (mol-1 dm3 cm-1); MS (70 
eV): m/z = 314 (M+, 41), 300 (15), 288 (28), 91 (63), 44 (100).
1-Oxyl-4-(t-butyldimethylsilyloxymethyl)-2,2,5,5-tetramethyl-2,5-dihydro-
1H-pyrrol-3-carbaldehyde Radical C15H30NO3Si (13) :
To a stirred solution of alcohol 12 (990 mg, 5.0 mmol) and imidazole (1.02 
g, 15.0 mmol) in dry DMF (7 mL)  t-butyl-dimethylchlorosilane (1.50 g) 
was added in 3-4 portions at 0 °C, then the solution was stirred for 24 h at 
ambient temperature. The solution was poured onto mixture of ice and sat. 
aq.  NaHCO3 solution  (50  mL),  extracted  with  Et2O  (3  x  20  mL),  the 
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organic phase was dried (MgSO4), filtered, evaporated and the residue was 
purified by flash column chromatography (gradient: hexane/Et2O 90%/10% 
to 70/30%) to give the title compound (1.06 g, 68%) as a yellow solid, Mp.: 
74 °C, Rf: 0,44 (hexane/Et2O 2:1). 1H NMR (500 MHz, CDCl3) δ = 0.12 (s, 
3H, SiCH3), 0.13 (s, 3H, SiCH3), 0.94 (s, 9H, C(CH3)3), 1.34 (s, 6H, CH3), 
1.39 (s, 6H, CH3), 4.59 (s, 2H, CH2), 10.27 (s, 1H, CHO) ppm; 13C NMR 
(125 MHz,  CDCl3)  δ  = -5.64 (SiCH3),  18.08 (SiC),  24.01 (CH3),  24.22 
(CH3), 25.67 (CH3), 58.28 (CH2), 67.95 (C), 69.60 (C), 139.38 (C), 159.96 
(C), 189.24 (CHO). IR (neat):   = 1658, 1625 cm-1; MS (70 eV):  m/z = 
312 (M+, 2), 240 (12), 183 (27), 75 (100).
 1-Oxyl-3-hydroxymethyl-2,2,5,5-tetramethyl-4-[(1E,3E,5E)-4-methyl-6-
(2,6,6-trimethylcyclohex-1-en-1-yl)hexa-1,3,5-trien-1-yl]-2,5-dihydro-1H-
pyrrole  Radical  C25H38NO2 (14):  To  a  stirred  solution  of  -
ionylidenethyltriphenyl-phosphonium  bromide  (2.72  g,  5.0  mmol)  in 
anhydr.  THF  (40  mL),  LDA  solution  (2.8  mL,  5.0  mmol  in 
THF/heptane/ethylbenzene) was added dropwise at -78 °C. After stirring 
the solution for 15 min., compound 13 (1.56 g, 5.0 mmol) dissolved in THF 
(10 mL) was added dropwise at -78 °C to the dark red solution and the 
stirring  was  continued  for  1h  at  -78  °C,  then the  reaction  mixture  was 
allowed  to  warm  to  room  temperature  and  stirred  at  this  temperature 
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overnight. The solution was diluted with Et2O (30 mL) and sat. aq. NH4Cl 
solution  (10  mL)  was  added.  The  organic  phase  was  separated,  dried 
(MgSO4), filtered and evaporated. The residue was dissolved in THF (20 
mL) Bu4NF .  xH2O (1.30 g, 5.0 mmol) was added in one portion and the 
reaction mixture was stirred for 15 min. at room temperature, then Et2O (20 
mL) was added, the reaction mixture was washed with water (20 mL), the 
organic phase was separated, dried (MgSO4), filtered and evaporated. The 
chromatographic purification of the crude product (gradient: hexane/EtOAc 
90%/10% to 70%/30%) offered compound  14 as a pale yellow solid 691 
mg (36%),  Mp.:  106 °C;  Rf:  0.47 (hexane/EtOAc 2:1).  IR (neat):   = 
3481, 1591 cm-1; UV-Vis (ethanol, c = 1.85.10-5 mol dm-3): max () = 334 
(37900), nm (mol-1 dm3 cm-1); MS (70 eV): m/z = 348 (M+, 70), 369 (10), 
354 (41), 42 (100). 
1-Oxyl-2,2,5,5-tetramethyl-4-[(1E,3E,5E)-4-methyl-6-(2,6,6-
trimethylcyclohex-1-en-1-yl)hexa-1,3,5-trien-1-yl]-2,5-dihydro-1H-pyrrol-
3-carbaldehyde Radical C25H36NO2 (5):
To a stirred solution of 14 alcohol (384 mg, 1.0 mmol) in CH2Cl2 (10 mL) 
activated  MnO2 (860  mg,  10.0  mmol)  was  added  and  the  mixture  was 
stirred  overnight  at  ambient  temperature  in  the  dark.  Then the  reaction 
mixture  was  filtered  through  Celite,  washed  with  CH2Cl2 (5  mL),  the 
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solvent was evaporated off and the residue was purified by flash column 
chromatography  with  gradient  elution  (hexane/Et2O  90%/10  %  to 
60%/40%) to give 5 aldehyde  210 mg (55%) as a yellow solid. Mp.: 100 
°C, Rf: 0.57 (hexane/Et2O 2:1).  1H NMR (500 MHz, CDCl3) δ = 1.10 (s, 
6H, CH3), 1.46 (s, 12H, CH3), 1.55 (s, 2H, CH2), 1.69 (s, 2H, CH2), 1.79 (s, 
3H, CH3), 2.06 (s, 3H, CH3), 2.09 (m, 2H, CH2), 6.22 (m, 2H, CH), 6.41 (d, 
1H, CH), 6.53 (d, 1H, CH), 7.09 (dd, 1H, CH), 10.02 (s, 1H, CHO);  13C 
NMR (125 MHz, CDCl3) δ = 12.92 (CH3), 19.06 (CH2), 21.59 (CH3), 24.31 
(CH3),  24.80 (CH3),  28.82 (CH3),  32.98 (CH2),  34.12 (C),  39.47 (CH2), 
67.80 (C), 69.58 (C), 120.36 (CH), 129.17 (CH), 129.61 (CH), 130.23 (C), 
135.52 (CH), 136.74 (CH), 137.50 (C), 138.52 (C), 140.79 (C), 159.48 (C), 
187.62 (CHO). IR (neat):  = 1646, 1565, 1540 cm-1; UV-Vis (ethanol, c = 
1.73.10-5 mol dm-3): max () = 384 (21300), 258 (8300) nm (mol-1 dm3 cm-
1); MS (70 eV): m/z = 382 (M+, 16), 352 (29),  377 (17), 43 (100).
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Figure Captions
Fig.  1 Retinal  (1),  previously  reported  (2,  3)  and  herein  reported 
paramagnetic retinal derivatives (4, 5).
Fig.  2  Reagents  and  conditions:  (a)  4-diethoxyphosphinyl-3-methyl-2-
butenoate  (1.5  equiv.),  BuLi  (1.2  equiv),  THF,  30  min.,  -78  °C,  then 
compound 6 or  9 (1.0 equiv.), 30 min., -78 °C, -78 °C r.t., 8h, quench 
with aq. NH4Cl 39-48%; (b) MeOH, 10% aq. NaOH (excess), 8h, then H+ 
pH=4, 35- 42%; (c) Et3N (2.0 equiv), ClCO2Et (1.0 equiv), Et2O, 0 °C, 3h, 
filtration, evaporation the solvent off then 1.1 equiv NaBH4, EtOH, 2h, 0 
°C, work-up then activated MnO2 (10 equiv.), CH2Cl2, r.t. 8h, 25-31%.
Fig. 3 Reagents and conditions: (a) TBDMSCl (2.0 equiv.), imidazole (3.0 
equiv.),  DMF,  0  °C   r.t.,   24h,  68  %;  (b)  -ionylidenethyltriphenyl-
phosphonium bromide (1.0 equiv.),  LDA (1.0 equiv.),  THF,  -78 °C,  15 
min., then compound  13 (1.0 equiv.), -78 °C , 1h, then -78 °Cr.t., 1h, 
work-up, then Bu4NF (1.0 equiv.),  THF, r.t.  15 min. 36%; (c) activated 
MnO2 (10.0 equiv.), CH2Cl2, r.t. 8h, 55%.
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Fig. 3
N
CHO
O
HO
N
CHO
O
O
N
OH
O
12
a
13
b
14
c
5
Si
221
MoChem_Template_Vers 3.2 May 2011
Graphics for use in the Table of Contents
New paramagnetic  retinal  analogues  have  been  synthesized  by  Horner-
Wadsworth-Emmons  and  Wittig  reactions.  In  these  new  analogues  the 
pyrroline nitroxide moiety is situated in the place of -ionone ring or at the 
end of the polyene chain.
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